PERSONALIS
(NASDAQ: PSNL)

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

5.750

+0.490 (+9.32%)
Range 5.600 - 7.190   (28.39%)
Open 5.690
Previous Close 5.260
Bid Price 2.020
Bid Volume 8
Ask Price 2.030
Ask Volume 18
Volume 8,014,649
Value -
Remark
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis